Esperite CEO opens trading at Amsterdam exchange
Esperite CEO Frédéric Amar sounds the gong to open trading at the Amsterdam exchange.
Biotech company Esperite (ticker symbol: ESP) is a leading international company in predictive medicine and diagnostic medical tests. The company, headquartered in Zutphen, was founded in 2000 and was listed on Euronext Amsterdam on 22 October 2009.
For more information: www.esperite.com